Free shipping on all orders over $ 500

A-769662

Cat. No. M3444
A-769662 Structure
Size Price Availability Quantity
Free Sample (0.5-1 mg)  USD 0 In stock
10mM*1mL in DMSO USD 60  USD60 In stock
5mg USD 58  USD58 In stock
10mg USD 84  USD84 In stock
25mg USD 168  USD168 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

A-769662 is a potent, reversible AMP-activated protein kinase (AMPK) activator with an EC50 of 0.8 μM.A-769662 displays selectivity towards β1 subunit-containing heterotrimers. A-769662 not only inhibits fatty acid synthesis with an IC50 of 3.2 μM but also decreases plasma glucose and triglyceride levels in vivo. The addition of A-769662 to mouse embryonic fibroblasts or primary mouse hepatocytes stimulates phosphorylation of acetyl-CoA carboxylase (ACC), effects that are completely abolished in AMPK-alpha1 (-/-)alpha2 (-/-) cells but not in TAK1 (-/-) mouse embryonic fibroblasts. Phosphorylation of AMPK and ACC in response to A-769662 is also abolished in isolated mouse skeletal muscle lacking LKB1, a major upstream kinase for AMPK in this tissue. A-769662 directly prevents the alpha (1)-isoform of the Na (+)-K (+)-ATPase which is purified from rat and human kidney cells in vitro with IC50 of 57 μM and 220 μM, respectively. Suppression of the Na (+)-K (+)-ATPase by 100 μM ouabain decreases sodium pump activity and cell surface abundance, similar to the effect of A769662 (A 769662; A-769662), without influencing the phosphorylation of AMPK and ACC.

Customer Product Validations & Biological Datas
Source Front Physiol (2018). Figure 6. A-769662
Method i.p.
Cell Lines mice
Concentrations 30 mg/kg/day
Incubation Time 6 weeks
Results A-769662 (30 mg/kg/day) was administered q.d. for 6 weeks. During treatment, A-769662 did not affect food intake in either chow-fed or HFD-fed mice
Protocol (for reference only)
Cell Experiment
Cell lines MEF cells
Preparation method Treating or not cell viability of MEF cells with A-769662 is performed as follows: harvesting cells by trypsinization and incubating with 0.5 mg/mL RNase and 50 μg/mL propidium iodine at room temperature in the dark; analyzing cell viability by flow cytometry using a FACScanto flow cytometer, using an excitation laser at 488 nm and a propidium iodine fluorescence detection at 600 nm. Cells are harvested by trypsinization, collected by centrifugation, washed in PBS and fixed overnight in 80% ethanol at -20 °C to determine the proportion of cells in each phase of the cell cycle. Subsequently, these fixed cells are centrifuged to remove the fixative and incubated for 20 minutes in the dark at room temperature in PBS containing 0.5 mg/mL RNase and 50 μg/mL propidium iodine. Flow cytometry analysis is performed as above. Using the MODFIT progra to determine the proportion of cells in G1, S, and G2 is determined . Using a camera to take Cell culture pictures at the indicated times coupled to an inverted microscope with a 20 × objective.
Concentrations 300 μM
Incubation time 24 hours
Animal Experiment
Animal models Sprague Dawley rats
Formulation A-769662 is dissolved in DMSO
Dosages 30 mg/kg
Administration Administered via i.p.
Chemical Information
Molecular Weight 360.39
Formula C20H12N2O3S
CAS Number 844499-71-4
Solubility (25°C) DMSO 35 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Basem M Abdallah, et al. A-769662 stimulates the differentiation of bone marrow-derived mesenchymal stem cells into osteoblasts via AMP-activated protein kinase-dependent mechanism

[2] Franziska Kopietz, et al. A-769662 inhibits adipocyte glucose uptake in an AMPK-independent manner

[3] Maryam Rameshrad, et al. A-769662, a direct AMPK activator, attenuates lipopolysaccharide-induced acute heart and lung inflammation in rats

[4] Yalong Zhu, et al. A-769662 protects osteoblasts from hydrogen dioxide-induced apoptosis through activating of AMP-activated protein kinase (AMPK)

[5] Aurlie D Timmermans, et al. A-769662 potentiates the effect of other AMP-activated protein kinase activators on cardiac glucose uptake

Related AMPK Products
SAMS

SAMS peptide is a specific substrate for the AMP-activated protein kinase (AMPK).

Marein

Marein has the neuroprotective effect due to a reduction of damage to mitochondria function and activation of the AMPK signal pathway.

Malvidin-3-O-arabinoside chloride

Malvidin-3-O-arabinoside chloride ameliorates ethyl carbamate-induced oxidative damage by stimulating AMPK-mediated autophagy.

AMPK activator 12

AMPK activator 12 is a potent AMPK activator and GDF15 inducer.

Kazinol U

Kazinol U inhibits melanogenesis through the inhibition of tyrosinase-related proteins via AMPK activation.

  Catalog
Abmole Inhibitor Catalog




Keywords: A-769662 supplier, AMPK, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.